Research has demonstrated that AOD-9604 increases beta-3 receptor expression in adipose tissue, potentially improving mobilization from resistant areas
PDA Journal of Pharmaceutical Science & Technology, 50, 261-266
Unlike some peptides that mainly reduce appetite, 5-Amino-1MQ targets the NNMT enzyme to prevent fat storage, supporting a metabolic approach to fat loss rather than simply appetite suppression Yes, 5-Amino-1MQ can be used in combination with other therapies like GLP-1 for enhanced weight loss and metabolic support
My most recent b12 test came back in 1300's which was happily shocking because at the time i had not had a b12 injection for appox 7 weeks prior, i just had not felt the need and then realized why
These limitations dont invalidate the positive safety findings but do suggest that comprehensive medical supervision remains appropriate for anyone using AOD-9604, particularly for off-label applications or extended treatment periods
A 2025 systematic review, Vasireddi et al., HSS J 2025, screened hundreds of articles and found the BPC-157 orthopaedic base to be almost exclusively animal or low-level studies, with only isolated small human reports and no rigorous randomised trials